122 related articles for article (PubMed ID: 37890508)
21. MiR-144-3p inhibits the proliferation and metastasis of pediatric Wilms' tumor cells by regulating Girdin.
Liu CL; Wang WH; Sun YL; Zhuang HW; Xu M; Chen HF; Liu JX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7671-7678. PubMed ID: 30536309
[TBL] [Abstract][Full Text] [Related]
22. CircSLC7A6 promotes the progression of Wilms' tumor via microRNA-107/ ABL proto-oncogene 2 axis.
Xu J; Hao Y; Gao X; Wu Y; Ding Y; Wang B
Bioengineered; 2022 Jan; 13(1):308-318. PubMed ID: 34787058
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA MIAT acts as an oncogene in Wilms' tumor through regulation of DGCR8.
Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10257-10263. PubMed ID: 31841180
[TBL] [Abstract][Full Text] [Related]
24. The roles of microRNAs in Wilms' tumors.
Yu X; Li Z; Chan MT; Wu WK
Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer-associated transcript 2 contributes to nephroblastoma progression.
Zhu J; Zhu Z; Cai P; Gu Z; Wang J
J Gene Med; 2022 Feb; 24(2):e3292. PubMed ID: 33142356
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA DLEU2 regulates the progression of Wilm's tumor via miR-539-3p/HOXB2 axis.
Yong J; He J; Ning F
J Pediatr Urol; 2023 Feb; 19(1):25-32. PubMed ID: 36209036
[TBL] [Abstract][Full Text] [Related]
27. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4145-4151. PubMed ID: 32373950
[TBL] [Abstract][Full Text] [Related]
29. Over-Expression of miR-21 and Lower PTEN Levels in Wilms' Tumor with Aggressive Behavior.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
Tohoku J Exp Med; 2017 May; 242(1):43-52. PubMed ID: 28529243
[TBL] [Abstract][Full Text] [Related]
30. Tumor-suppressive activity of Hnf1β in Wilms' tumor.
Liu Y; Kanyomse Q; Xie Y
Biosci Biotechnol Biochem; 2019 Nov; 83(11):2008-2015. PubMed ID: 31038395
[TBL] [Abstract][Full Text] [Related]
31. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
Zhu X; Zhang H; Xu J
Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.
Wang HF; Zhang YY; Zhuang HW; Xu M
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3360-3369. PubMed ID: 28829507
[TBL] [Abstract][Full Text] [Related]
35. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
36. Circ-PRMT5 stimulates the proliferative ability in Wilms' tumor through the miR-7-5p/KLF4 axis.
Zhang J; Quan Y; Su X; Qiu B; Dong Q
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):232-236. PubMed ID: 37715374
[TBL] [Abstract][Full Text] [Related]
37. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation.
Hu J; Pan J; Luo Z; Duan Q; Wang D
Cancer Gene Ther; 2021 Jun; 28(6):602-618. PubMed ID: 33204001
[TBL] [Abstract][Full Text] [Related]
39. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
40. Krüppel-like factor 5-induced overexpression of long non-coding RNA DANCR promotes the progression of cervical cancer via repressing microRNA-145-3p to target ZEB1.
Hu C; Han Y; Zhu G; Li G; Wu X
Cell Cycle; 2021 Jul; 20(14):1441-1454. PubMed ID: 34233586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
